Variant report
Variant | nsv981930 |
---|---|
Chromosome Location | chr8:39717117-39717950 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:18)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:18 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | FOS | chr8:39717213-39717670 | MCF10A-Er-Src | breast: | n/a | chr8:39717398-39717409 chr8:39717373-39717384 chr8:39717400-39717409 |
2 | FOS | chr8:39717181-39717698 | MCF10A-Er-Src | breast: | n/a | chr8:39717398-39717409 chr8:39717373-39717384 chr8:39717400-39717409 |
3 | FOS | chr8:39717216-39717652 | MCF10A-Er-Src | breast: | n/a | chr8:39717398-39717409 chr8:39717373-39717384 chr8:39717400-39717409 |
4 | FOS | chr8:39717166-39717622 | HUVEC | blood vessel: | n/a | chr8:39717398-39717409 chr8:39717373-39717384 chr8:39717400-39717409 |
5 | FOS | chr8:39717221-39717790 | MCF10A-Er-Src | breast: | n/a | chr8:39717398-39717409 chr8:39717373-39717384 chr8:39717400-39717409 |
6 | FOSL1 | chr8:39717207-39717600 | HCT-116 | colon: | n/a | chr8:39717400-39717409 |
7 | FOSL1 | chr8:39717188-39717664 | HCT-116 | colon: | n/a | chr8:39717400-39717409 |
8 | FOSL2 | chr8:39717274-39717667 | SK-N-SH | brain: | n/a | chr8:39717400-39717409 |
9 | JUN | chr8:39717231-39717600 | HUVEC | blood vessel: | n/a | chr8:39717400-39717409 |
10 | JUND | chr8:39717232-39717646 | SK-N-SH | brain: | n/a | chr8:39717400-39717409 |
11 | JUND | chr8:39717170-39717628 | Hela-S3 | cervix: | n/a | chr8:39717400-39717409 |
12 | JUND | chr8:39717191-39717724 | HCT-116 | colon: | n/a | chr8:39717400-39717409 |
13 | MYC | chr8:39717275-39717652 | MCF10A-Er-Src | breast: | n/a | chr8:39717399-39717408 |
14 | MYC | chr8:39717241-39717645 | MCF10A-Er-Src | breast: | n/a | chr8:39717399-39717408 |
15 | STAT3 | chr8:39717201-39717618 | MCF10A-Er-Src | breast: | n/a | n/a |
16 | STAT3 | chr8:39717261-39717638 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | STAT3 | chr8:39717301-39717650 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | STAT3 | chr8:39717266-39717576 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
No data |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IDO1-1 | chr8:39717738-39718044 | NONHSAT126184 |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000253332 | TF binding region |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564987276 | chr8:39717127-39717128 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs189636072 | chr8:39717131-39717132 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs540977283 | chr8:39717229-39717230 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs561066358 | chr8:39717230-39717231 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs530104064 | chr8:39717298-39717299 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs550382375 | chr8:39717344-39717345 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs182318492 | chr8:39717356-39717357 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs374602339 | chr8:39717470-39717471 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs186712697 | chr8:39717481-39717482 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs146515047 | chr8:39717511-39717512 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs536522666 | chr8:39717538-39717539 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs566336235 | chr8:39717554-39717555 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs191569489 | chr8:39717561-39717562 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs375866120 | chr8:39717625-39717626 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs11994361 | chr8:39717653-39717654 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs118061669 | chr8:39717654-39717655 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs556353863 | chr8:39717682-39717683 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs576156996 | chr8:39717711-39717712 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs79974060 | chr8:39717724-39717725 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs558429372 | chr8:39717725-39717726 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs140825787 | chr8:39717739-39717740 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
22 | rs112446678 | chr8:39717744-39717745 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
23 | rs143186852 | chr8:39717749-39717750 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
24 | rs76425707 | chr8:39717773-39717774 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
25 | rs184783750 | chr8:39717774-39717775 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
26 | rs563947266 | chr8:39717781-39717782 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
27 | rs532607046 | chr8:39717795-39717796 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
28 | rs145441501 | chr8:39717800-39717801 | Weak transcription Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
29 | rs560111840 | chr8:39717820-39717821 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
30 | rs373976283 | chr8:39717855-39717856 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
31 | rs547453460 | chr8:39717856-39717857 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
32 | rs567132108 | chr8:39717903-39717904 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs536396651 | chr8:39717914-39717915 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs562917411 | chr8:39717948-39717949 | Enhancers | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Prostate cancer | 16573809 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Cancer | 21637783 | CNVD |
Breast cancer | 20837533 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 22429812 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Breast cancer | 21264507 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 21386901 | CNVD |
Prostate cancer | 21088497 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 20940404 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Gastric cancer | 17167181 | CNVD |
Prostate cancer | 16705090 | CNVD |
8p-syndrome | 17576883 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Lung adenocarcinoma | 19525976 | CNVD |
Lung cancer | 19525976 | CNVD |
Prostate cancer | 17245344 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Cancer | 16751803 | CNVD |
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Lung cancer | 18438408 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Immune disease | 21572526 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Kallmann Syndrome 2 | 22470819 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Developmental delay | 21373258 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 17603634 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Testicular cancer | 18059402 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Bladder cancer | 19088036 | CNVD |
Non-muscle invasive bladder neoplasm | 19445696 | CNVD |
Breast cancer | 17001308 | CNVD |
Breast cancer | 17157792 | CNVD |
Cancer | 17001308 | CNVD |
Cancer | 18840272 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Chordoma | 18071362 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 16608533 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21785460 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 16620391 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Cancer | 20164920 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Medulloblastoma | 19270706 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:39704800-39717800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr8:39707400-39717400 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr8:39715200-39717600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr8:39717000-39717400 | Weak transcription | IMR90 fetal lung fibroblasts Cell Line | lung |
5 | chr8:39717000-39717800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
6 | chr8:39717000-39717800 | Enhancers | HSMM | muscle |
7 | chr8:39717000-39720800 | Enhancers | HUVEC | blood vessel |
8 | chr8:39717400-39717800 | Enhancers | Placenta Amnion | Placenta Amnion |
9 | chr8:39717400-39718000 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
10 | chr8:39717400-39718000 | Enhancers | NH-A | brain |
11 | chr8:39717600-39718000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
12 | chr8:39717600-39718000 | Enhancers | Placenta | Placenta |
13 | chr8:39717600-39718000 | Enhancers | HMEC | breast |
14 | chr8:39717600-39718000 | Enhancers | NHLF | lung |
15 | chr8:39717800-39718000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |